Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.55 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 2/20 | 0.48 |
| ▸ | CES1 | P23141 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| O-Xylene SCHEMBL28016180 | 0.85 | ALDH1A1 (0.50) | TSHRACHEALDH1A1CYP1A2TP53 | |
| Toluene SCHEMBL11041731 | 0.84 | LMNA (0.39) | LMNATSHRALOX12ACHEALDH1A1 | |
| Pivalate SCHEMBL27449045 | 0.82 | LMNA (0.58) | LMNATSHRALOX12ACHEALDH1A1 | |
| Toluene SCHEMBL124611 | 0.81 | LMNA (0.65) | LMNATSHRALOX12ACHEALDH1A1 | |
| Toluene SCHEMBL1850918 | 0.81 | LMNA (0.65) | LMNATSHRALOX12ACHEALDH1A1 | |
| Toluene SCHEMBL4861938 | 0.81 | LMNA (0.65) | LMNATSHRALOX12ACHEALDH1A1 | |
| Toluene SCHEMBL7355317 | 0.81 | LMNA (0.73) | LMNATSHRALOX12ACHEALDH1A1 | |
| Toluene SCHEMBL48134 | 0.81 | LMNA (0.73) | LMNATSHRALOX12ACHEALDH1A1 | |
| Toluene SCHEMBL4498352 | 0.81 | TSHR (0.73) | LMNATSHRALOX12ACHEALDH1A1 | |
| Toluene SCHEMBL2914390 | 0.81 | LMNA (0.73) | LMNATSHRALOX12ACHEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114599664-B | Glycoside compound, amide compound, and method for producing polynucleotide using these compounds | 住友化学株式会社 | 2025-03-28 | — | — | CN | disclosed |
| CN-114502566-B | Method for producing nucleic acid oligomer | 住友化学株式会社 | 2025-02-11 | — | — | CN | disclosed |
| CN-115003680-B | Method for preparing nucleic acid oligomer | 住友化学株式会社 | 2025-01-28 | — | — | CN | disclosed |
| CN-113646083-B | Inorganic porous carrier and method for producing nucleic acid using same | 住友化学株式会社 | 2024-06-07 | — | — | CN | disclosed |
| CN-113677432-B | Inorganic porous carrier and method for producing nucleic acid using same | 住友化学株式会社 | 2024-06-07 | — | — | CN | disclosed |
| CN-111684073-B | Method for producing nucleic acid molecule | 住友化学株式会社 | 2024-01-05 | — | — | CN | disclosed |
| CN-115551805-B | Inorganic porous substrate, inorganic porous support, and method for producing nucleic acid | 住友化学株式会社 | 2023-10-20 | — | — | CN | disclosed |
| CN-112020507-B | Amide compound and method for producing polynucleotide using same | 住友化学株式会社 | 2023-10-10 | — | — | CN | disclosed |
| US-20230256425-A1 | INORGANIC POROUS SUBSTRATE, INORGANIC POROUS SUPPORT, AND NUCLEIC ACID PRODUCTION METHOD | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230242570-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-08-03 | — | — | US | disclosed |
| CN-106749928-A | The composition and preparation method of a kind of GMA graft modifications LLDPE | 黄山贝诺科技有限公司 | 2017-05-31 | — | — | CN | disclosed |
| US-20150315229-A1 | METHOD FOR LIQUID-PHASE SYNTHESIS OF NUCLEIC ACID | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-11-05 | — | — | US | disclosed |
| EP-2921499-A1 | METHOD FOR LIQUID-PHASE SYNTHESIS OF NUCLEIC ACID | Takeda Pharmaceutical Company Limited (JP) | 2015-09-23 | — | — | EP | disclosed |
| US-6326494-B1 | LASER DYES | BASF AKTIENGESELLSCHAFT (DE) | 2001-12-04 | — | — | US | disclosed |
| US-6184378-B1 | PIGMENTS, LASER DYES AND PRECURSORS FOR PREPARING FLUORESCENT DYES, POLYMERIC COLORANTS, | BASF AKTIENGESELLSCHAFT (DE) | 2001-02-06 | — | — | US | disclosed |
| US-6143905-A | REACTING 1,7-DIBROMOPERYLENE-3,4,9,10-TETRACARBOXYLIC DIANHYDRIDE OR TETRACARBOXYLIC ACID IN PRESENCE OF APROTIC SOLVENT WITH A PRIMARY AMINE TO FORM DIIMIDE, REACTING DIIMIDE WITH AROMATIC ALOCHOL OR THIOL, AND HYDROLYZING | BASF AKTIENGESELLSCHAFT (DE) | 2000-11-07 | — | — | US | disclosed |
| US-6136976-A | REACTING PERYLENE-3,4,9,10-TETRACARBOXYLIC ACID OR ITS ANHYDRIDE WITH AN AMIDE IN PRESENCE OF INTER DILUENT AND TRANSITION METAL CATALYST OR ZINC METAL OR SALT CATALYST UNDER SUPERATMOSPHERIC PRESSURE | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-24 | — | — | US | disclosed |
| US-6063181-A | 1,7-disubstituted perylene-3,4,9, 10-tetracarboxylic acids, their dianhydrides and diimides of said acids | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-16 | — | — | US | disclosed |
| US-5808073-A | CATALYTIC AMINATION OF THE CORRESPONDING PERYLENETETRACARBOXYLIC ACID OR ANHYDRIDE WITH PRIMARY AMINE IN TERTIARY AMINE SOLVENT | BASF AKTIENGESELLSCHAFT (DE) | 1998-09-15 | — | — | US | disclosed |
| US-4508912-A | UNING METAL OXIDE, HYDROXIDE, ACID OR ACID SALT, OR ORGANOBASIC COMPOUND CATALYST | AJINOMOTO COMPANY, INCORPORATED (JP) | 1985-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150315229-A1 | METHOD FOR LIQUID-PHASE SYNTHESIS OF NUCLEIC ACID | POLM, POLRMT, RNMT | LMNA 233/4885TSHR 495/4885ALOX12 2904/4885 |
| US-20230256425-A1 | INORGANIC POROUS SUBSTRATE, INORGANIC POROUS SUPPORT, AND NUCLEIC ACID PRODUCTION METHOD | DNMT3L, FBL, SIK1 | LMNA 373/4885TSHR 4846/4885ALOX12 3594/4885 |
| US-20230242570-A1 | METHOD FOR PRODUCING NUCLEIC ACID OLIGOMER | FBL, POLI, POLL | LMNA 1361/4885TSHR 1662/4885ALOX12 2611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.